Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Karsten Kratz-Albers"'
Autor:
Susanna Hegewisch-Becker, Karsten Kratz-Albers, Jan Wierecky, Steffen Gerhardt, Daniel Reschke, Jens Borchardt, Ralf Reichelt, Felix Walter Friedrich
Publikováno v:
Future oncology (London, England).
Background: Pancreatic cancer is one of the most aggressive cancers, with comparatively poor outcomes despite the use of multiagent conventional chemotherapy regimens. Real-world data from clinical practice are still rare but are the basis for unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3e52fbbcb8d2859053cfbf13f20014
https://pubmed.ncbi.nlm.nih.gov/36533962
https://pubmed.ncbi.nlm.nih.gov/36533962
Autor:
Christian Wilms, Kristina Middelberg-Bisping, Karsten Kratz-Albers, Christoph Schliemann, Christian Schwöppe, Mirjam Gerwing, Hartmut Schmidt, Georg Lenz, Bjorna Berning, Wolfgang E. Berdel, Wolfgang Hartmann, Hauke Heinzow, Andrew F. Berdel, Joachim Gerss, Eike Bormann, Torsten Kessler, Saliha Harrach, Ursula Stalmann, Moritz Wildgruber, Linus Angenendt, Stefanie Wiebe, Jörn C. Albring, Walter Heindel, Rolf M. Mesters, Tobias Krähling, Eva Wardelmann, Anna Hansmeier
Publikováno v:
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1488, p 1488 (2020)
Volume 12
Issue 6
Cancers, Vol 12, Iss 1488, p 1488 (2020)
Background: Aminopeptidase N (CD13) is present on tumor vasculature cells and some tumor cells. Truncated tissue factor (tTF) with a C-terminal NGR-peptide (tTF-NGR) binds to CD13 and causes tumor vascular thrombosis with infarction. Methods: We trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904a261c2977d8190201cd4179bdc920
https://doi.org/10.3390/cancers12061488
https://doi.org/10.3390/cancers12061488
Autor:
Karsten Kratz-Albers
Publikováno v:
Forum. 33:167-168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb9e4f0fc7a8b1b529900cb07b9184b2
https://doi.org/10.1007/s12312-018-0390-7
https://doi.org/10.1007/s12312-018-0390-7
Autor:
Thomas Büchner, Wolfram Grüning, Regina Fenski, Rainer Schmidt, Wolfgang E. Berdel, Itaru Matsumura, S Serve, Carsten Müller, Claudia Steur, Hubert Serve, Hartmut Halfter, Karsten Kratz-Albers, Joachim Kienast, Kanakura Y, Masao Mizuki
Publikováno v:
Blood. 96:3907-3914
Somatic mutations of the receptor tyrosine kinase Flt3 consisting of internal tandem duplications (ITD) occur in 20% of patients with acute myeloid leukemia. They are associated with a poor prognosis of the disease. In this study, we characterized th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a19aa01d6356ce42a08cf8d71b6bbce
https://doi.org/10.1182/blood.v96.12.3907
https://doi.org/10.1182/blood.v96.12.3907
Autor:
Cornelia Failenschmid, Wolfram Brugger, Marcus M Schittenhelm, Hubert Serve, Karsten Kratz-Albers, Lothar Kanz, Frank Bautz, Robert Möhle
Publikováno v:
British Journal of Haematology. 110:563-572
The chemokine stromal cell-derived factor-1 (SDF-1) that is released by bone marrow (BM) stromal cells and contributes to stem cell homing may also play a role in the trafficking of leukaemic cells. We analysed SDF-1-induced intracellular calcium flu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96bd54ef2787afce1ff5f2d03a360e10
https://doi.org/10.1046/j.1365-2141.2000.02157.x
https://doi.org/10.1046/j.1365-2141.2000.02157.x
Autor:
K Flesch, Wolfgang E. Berdel, Elisabeth Oelmann, Stefan Schwartz, Hubert Serve, R Fenski, S Serve, Masao Mizuki, Joachim Kienast, Karsten Kratz-Albers, R. Leo
Publikováno v:
British Journal of Haematology. 108:322-330
The receptor tyrosine kinase Flt3 is expressed on leukaemic blasts of most cases with acute myeloid leukaemia (AML). In order to evaluate the presence and significance of constitutive activation of Flt3 for leukaemogenesis, we (1) analysed the expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a708ef25dcf3da20fa6dba13716dcb6
https://doi.org/10.1046/j.1365-2141.2000.01831.x
https://doi.org/10.1046/j.1365-2141.2000.01831.x
Autor:
Hubert Serve, Thomas Büchner, Michael Zühlsdorf, Karsten Kratz-Albers, Regine Leo, Wolfgang E. Berdel
Publikováno v:
Blood. 92:4485-4487
To the Editor: A novel hematopoietic stem and progenitor cell marker, monoclonal antibody (MoAb) AC133, was recently published by Miraglia et al[1][1] and Yin et al[2][2] in the December 15, 1997 issue of Blood. AC133 recognizes only CD34 bright and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722b3f6dbc6cac2f78e21155a80ce090
https://doi.org/10.1182/blood.v92.11.4485.423a57f_4485_4487
https://doi.org/10.1182/blood.v92.11.4485.423a57f_4485_4487
Autor:
Krämer D, Wallrapp C, Donald Small, Teller S, Frank-D. Böhmer, Sylvia-Annette Böhmer, Joachim Schwäble, Karsten Kratz-Albers, Thomas Beckers, Tse Kf, Siavosh Mahboobi, Hubert Serve
Publikováno v:
Leukemia. 16(8)
Aberrant expression and activating mutations of the class III receptor tyrosine kinase Flt3 (Flk-2, STK-1) have been linked to poor prognosis in acute myeloid leukemia (AML). Inhibitors of Flt3 tyrosine kinase activity are, therefore, of interest as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceea944f5b6ccf779337f15fda25dd5a
https://pubmed.ncbi.nlm.nih.gov/12145694
https://pubmed.ncbi.nlm.nih.gov/12145694
Autor:
Wolfram Brugger, Stefan Scheding, Lothar Kanz, John P. Mc Kearn, Thomas Büchner, Hans J. Bühring, Robert Möhle, Karsten Kratz-Albers, Charles M. Baum
Publikováno v:
Experimental hematology. 28(3)
Objective The additional transplantation of ex vivo-generated megakaryocytic cells might enable the clinician to ameliorate or abrogate high-dose chemotherapy-induced thrombocytopenia. Therefore, the ex vivo expansion of CD34 + PBPC was systematicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b49870c4264732e0a5d7fd769979c4
https://pubmed.ncbi.nlm.nih.gov/10720698
https://pubmed.ncbi.nlm.nih.gov/10720698
Autor:
Hubert Serve, Wolfgang E. Berdel, J Kienast, Th. Büchner, Karsten Kratz-Albers, H. Ostermann, R. Leo
Publikováno v:
Transplantation in Hematology and Oncology ISBN: 9783642640414
The results of multicenter studies demonstrate a 70% rate of complete remission (CR) in adults with acute myelogenous leukemia (AML). Nevertheless, 2/3 of patients relapse during the first two years after induction therapy [2–4]. Therapeutic strate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::934ba24af688138374b6fd505852fe29
https://doi.org/10.1007/978-3-642-59592-9_14
https://doi.org/10.1007/978-3-642-59592-9_14
